Sophia Randolph, Chief Medical Officer at ALX ONCOLOGY HOLDINGS INC (ALXO), sold 12,776 shares at $62.12 ($793K) on 2021-05-10, disclosed to the SEC on 2021-05-11.
Open-market sale of $793k ALXO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.12 | 1,925 | $118K | 14.8% |
| 2 | $62.12 | 4,433 | $275K | 34.7% |
| 3 | $62.12 | 4,433 | $275K | 34.7% |
| 4 | $62.79 | 956 | $60K | 7.6% |
| 5 | $62.79 | 956 | $60K | 7.6% |
| 6 | $64.56 | 73 |
| $5K |
| 0.6% |
| Total | $62.08 avg | 12,776 | $793K | 100% |
| Filing → |
| ALXO | SELL | 2024-05-15 | $353K | — | Filing → |
| ALXO | SELL | 2024-01-03 | $47K | — | Filing → |
| ALXO | SELL | 2023-07-05 | $12K | — | Filing → |